Characterization of Protease Activity of Nsp3 from SARS-CoV-2 and Its in Vitro Inhibition by Nanobodies
Synergism of Interferon-beta with Antiviral Drugs Against SARS-CoV-2 Variants
Development and Optimisation of a High-throughput Screening Assay for in Vitro AntiSARS-CoV-2 Activity: Evaluation of 5676 Phase 1 Passed Structures
Reduced Interferon Antagonism But Similar Drug Sensitivity in Omicron Variant Compared to Delta Variant SARS-CoV-2 Isolates
Omicron-induced Interferon Signalling Prevents Influenza A Virus Infection
SARS-CoV-2 Omicron Variant Virus Isolates are Highly Sensitive to Interferon Treatment
Identification of Novel Antiviral Drug Candidates Using an Optimized SARS-CoV-2 Phenotypic Screening Platform
Repurposing of the Antibiotic Nitroxoline for the Treatment of Mpox
The COVID-19 PHARMACOME: a Method for the Rational Selection of Drug Repurposing Candidates from Multimodal Knowledge Harmonization
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
CD47 as a Potential Biomarker for the Early Diagnosis of Severe COVID-19
Targeting Pentose Phosphate Pathway for SARS-CoV-2 Therapy
Detection and Infectivity of SARS-CoV-2 in Exhumated Corpses
SARS-CoV-2 and SARS-CoV Differ in Their Cell Tropism and Drug Sensitivity Profiles
Impact of the COVID-19 Pandemic on the Circulation of Other Pathogens in England
Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model
COVID-19-related Coagulopathy - is Transferrin a Missing Link?